Long‐term health economic evaluation of automated insulin delivery system compared with continuous subcutaneous insulin infusion pumps and <scp>CGM</scp> in a real‐world setting in Finnish paediatric and adult individuals with type 1 diabetes
Based on the results of this first cost-effectiveness study conducted in Finland, a willingness-to-pay (WTP) threshold of 50 000 EUR per QALY gained suggests that AID is more cost-effective than CSII plus CGM for the treatment of T1DM in a real-world setting.
Authors
- Reeta Rintamäki (ORCID: https://orcid.org/0000-0003-4678-5555)
- Janne Martikainen (ORCID: https://orcid.org/0000-0003-0855-3921)
- Jyrki Mustonen (ORCID: https://orcid.org/0000-0002-1400-5983)
- Hanna A. Leppänen (ORCID: https://orcid.org/0000-0002-5359-301X)
- Antti Saari (ORCID: https://orcid.org/0000-0003-4977-5432)
- Heta‐Leena Vallivaara
Institutions
- University of Eastern Finland (FI)
- North Karelia Central Hospital (FI)
- Kuopio University Hospital (FI)
- Etelä-Karjalan sosiaali ja terveyspiiri (FI)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1111/dom.16520
- Citations
- 7
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 9.06